Security Snapshot

Xtant Medical Holdings, Inc. - Common Stock (XTNT) Institutional Ownership

CUSIP: 98420P308

13F Institutional Holders and Ownership History from Q1 2018 to Q1 2026

Latest Period

Q1 2026

Institutions Reporting

34

Shares (Excl. Options)

80,736,006

Price

$0.56

Save this security page for your next review

Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.

Create free account and return here Sign in and return here Review latest holder period
Type / Class
Equity / Common Stock
Symbol
XTNT on NYSE
Shares outstanding
140,036,400
Price per share
$0.52
All holders as of 31 Mar 2026
Q1 2026
Total 13F shares
80,736,006
Total reported value
$45,051,748
% of total 13F portfolios
0%
Share change
-668,739
Value change
-$391,346
Number of holders
34
Price from insider filings
$0.52
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Key facts

  • XTNT - Xtant Medical Holdings, Inc. - Common Stock is tracked under CUSIP 98420P308.
  • 34 institutions reported positions in Q1 2026.
  • 2 significant owners is listed from Schedule 13D/13G reporting.

Change

  • Holder count moved from 35 to 34 between Q4 2025 and Q1 2026.
  • Reported value moved from $63,818,481 to $45,051,748.

Research use

  • You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
  • 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.

Evidence

Source: SEC Form 13F

Latest holder context comes from 34 institutions filings for Q1 2026.

Open SEC Evidence

Security key

98420P308

Latest holder period

Q1 2026

13F holders

34

13D/G owners

2

CIK / CUSIP context first

Open Q1 2026 holders XTNT full holder history Xtant Medical Holdings, Inc. SEC filings Xtant Medical Holdings, Inc. company facts Xtant Medical Holdings, Inc. insider transactions

Broader feeds

Latest 13F filings Latest 13D/G filings All securities

Significant Owners of Xtant Medical Holdings, Inc. - Common Stock (XTNT) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
Nantahala Capital Management, LLC 49% 0% $50,543,166 68,394,000 0% Nantahala Capital Management, LLC 01 Aug 2025
LYTTON LAURENCE W 5.5% -19% $5,545,441 -$1,268,237 7,702,002 -19% LYTTON LAURENCE W 31 Dec 2025

As of 31 Mar 2026, 34 institutional investors reported holding 80,736,006 shares of Xtant Medical Holdings, Inc. - Common Stock (XTNT). This represents 58% of the company’s total 140,036,400 outstanding shares.

Top 25 Institutional Shareholders

The largest institutional shareholders of Xtant Medical Holdings, Inc. - Common Stock (XTNT) together control 58% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.

Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
Nantahala Capital Management, LLC 49% 68,394,000 0% 2.4% $38,163,852
AWM Investment Company, Inc. 4.3% 5,976,910 -9.4% 0.37% $3,335,116
VANGUARD CAPITAL MANAGEMENT LLC 1.4% 2,014,603 0% 0% $1,124,148
RENAISSANCE TECHNOLOGIES LLC 0.71% 987,410 +7.3% 0% $550,975
GEODE CAPITAL MANAGEMENT, LLC 0.38% 529,214 +7.6% 0% $295,376
Crescent Grove Advisors, LLC 0.29% 412,024 0% 0.02% $229,909
Hillsdale Investment Management Inc. 0.26% 362,200 0% 0.01% $202,108
NANO CAP NEW MILLENNIUM GROWTH FUND L P 0.25% 350,000 +25% 0.18% $195,300
VANGUARD FIDUCIARY TRUST CO 0.18% 257,988 0% 0% $143,957
ACADIAN ASSET MANAGEMENT LLC 0.13% 180,299 -7.1% 0% $99,000
BRIDGEWAY CAPITAL MANAGEMENT, LLC 0.12% 164,100 0% 0% $91,568
CITADEL ADVISORS LLC 0.11% 161,011 -44% 0% $89,844
MILLENNIUM MANAGEMENT LLC 0.09% 132,354 -31% 0% $73,854
BlackRock, Inc. 0.08% 115,782 0% 0% $64,606
Mink Brook Asset Management LLC 0.08% 109,466 0% 0.03% $61,082
WIREGRASS INVESTMENT MANAGEMENT LLC 0.07% 103,000 0% 0.05% $57,474
Tradition Wealth Management, LLC 0.07% 100,297 0% 0% $55,966
NORTHERN TRUST CORP 0.07% 99,598 +73% 0% $55,576
Private Advisor Group, LLC 0.06% 85,000 0% 0% $47,430
XTX Topco Ltd 0.03% 37,933 0% $21,167
JANE STREET GROUP, LLC 0.02% 33,978 +77% 0% $18,960
STATE STREET CORP 0.02% 31,266 0% 0% $17,446
SEI INVESTMENTS CO 0.02% 24,760 0% $13,816
Kestra Advisory Services, LLC 0.01% 20,000 0% 0% $11,160
LAZARD ASSET MANAGEMENT LLC 0.01% 19,562 -14% 0% $10,916

Institutional Holders of Xtant Medical Holdings, Inc. - Common Stock (XTNT) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2026 Q1 80,736,006 $45,051,748 -$391,346 $0.56 34
2025 Q4 81,404,745 $63,818,481 +$760,014 $0.78 35
2025 Q3 80,064,653 $51,958,020 +$59,666 $0.65 29
2025 Q2 79,963,210 $59,092,411 +$9,527,080 $0.74 29
2025 Q1 96,332,001 $45,274,819 -$166,227 $0.47 26
2024 Q4 96,692,530 $42,834,946 -$1,064,038 $0.44 28
2024 Q3 98,215,048 $66,126,833 +$5,325,340 $0.68 27
2024 Q2 90,066,890 $56,742,224 -$435,632 $0.63 26
2024 Q1 90,374,385 $105,738,087 +$205,479 $1.17 33
2023 Q4 90,202,353 $101,928,562 -$82,302 $1.13 31
2023 Q3 90,276,097 $99,304,130 +$9,366,353 $1.10 28
2023 Q2 81,765,290 $76,033,381 -$53,515 $0.93 19
2023 Q1 81,854,114 $52,181,371 -$34,628 $0.64 21
2022 Q4 81,903,507 $54,055,554 +$144,724 $0.66 19
2022 Q3 81,682,735 $58,794,209 +$779,674 $0.72 12
2022 Q2 80,613,065 $41,878,151 +$4,656 $0.52 12
2022 Q1 80,534,844 $54,787,198 -$46,947 $0.68 15
2021 Q4 80,663,007 $45,172,000 +$87,373 $0.56 17
2021 Q3 80,508,571 $89,363,000 -$2,471,600 $1.11 12
2021 Q2 82,710,575 $134,818,000 +$13,336,837 $1.63 14
2021 Q1 74,502,096 $175,824,000 +$1,768,228 $2.36 14
2020 Q4 73,761,114 $88,226,000 +$76,215,399 $1.20 11
2020 Q3 10,131,401 $8,345,000 -$186,747 $0.82 12
2020 Q2 10,345,548 $9,310,000 -$902,433 $0.90 10
2020 Q1 11,672,319 $7,820,000 +$9,453 $0.67 11
2019 Q4 11,656,858 $18,653,000 -$32,980 $1.60 9
2019 Q3 11,675,943 $33,159,000 -$11,600 $2.84 12
2019 Q2 11,679,733 $35,039,000 +$50,902 $3.00 10
2019 Q1 11,662,801 $35,571,000 -$210,500 $3.05 9
2018 Q4 11,735,030 $18,894,000 +$69,173 $1.61 11
2018 Q3 11,691,562 $45,015,000 +$2,792,758 $3.85 11
2018 Q2 10,963,855 $60,850,000 +$2,123,813 $5.55 12
2018 Q1 10,569,679 $83,108,926 +$83,108,926 $7.89 11
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .